Sign Up Today and Learn More About Attovia Therapeutics Stock
Invest in or calculate the value of your shares in Attovia Therapeutics or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Attovia Therapeutics Stock (ATTH)
Attovia Therapeutics develops a pipeline of biotherapeutics for immune-mediated diseases.
About Attovia Therapeutics Stock
Founded
2023
Headquarters
Fremont, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Attovia Therapeutics Press Mentions
Stay in the know about the latest news on Attovia Therapeutics
Qiming Venture Partners adds two IPOs in a week, taking 2026 total to nine
kr-asia • Aug 11, 2026
Quartet of biotechs join Nasdaq after stellar IPOs
pharmaphorum • Aug 10, 2026
Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs
medcitynews • Aug 10, 2026
US IPO Weekly Recap: August kicks off with flurry of biotech IPOs
renaissancecapital • Aug 08, 2026
免疫介导疾病治疗领导者Attovia Therapeutics成功登陆纳斯达克
news • Aug 07, 2026
Attovia Therapeutics Management
Leadership team at Attovia Therapeutics
Chief Executive Officer and Founder
Tao Fu
Board Member
Colin Walsh
Join now and verify your accreditation status to gain access to:
- Attovia Therapeutics Current Valuation
- Attovia Therapeutics Stock Price
- Attovia Therapeutics Management
- Available deals in Attovia Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Attovia Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Attovia Therapeutics Revenue and Financials
- Attovia Therapeutics Highlights
- Attovia Therapeutics Business Model
- Attovia Therapeutics Risk Factors
- Attovia Therapeutics Research Report from SACRA Research
Trading Attovia Therapeutics Stock
How to invest in Attovia Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Attovia Therapeutics through EquityZen funds. These investments are made available by existing Attovia Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Attovia Therapeutics stock?
Shareholders can sell their Attovia Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 480K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 57K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
